BioMarin Pharmaceutical Inc. (BVMF:B1MR34)
Brazil · Delayed Price · Currency is BRL 139.16
-1.96 (-1.39%)
At close: Nov 6, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 56.28 billion as of November 13, 2025. Its market cap has decreased by -26.18% in one year.
Market Cap
56.28B
Enterprise Value
51.66B
Revenue
16.49B
Ranking
n/a
PE Ratio
20.29
Stock Price
139.16
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 813.63M to 56.28B, an increase of 6,817.49%. That is a compound annual growth rate of 17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 56.28B | -27.36% |
| Dec 31, 2024 | 77.48B | -12.09% |
| Dec 29, 2023 | 88.13B | -13.33% |
| Dec 30, 2022 | 101.68B | 12.51% |
| Dec 31, 2021 | 90.38B | 9.32% |
| Dec 31, 2020 | 82.67B | 35.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 2.94B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |